Cerebrovascular Accident Clinical Trial
— STROXCOOfficial title:
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
Verified date | July 2023 |
Source | University Hospital, Limoges |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Stroke is major public health issue. The investigators recommend post-stroke patients to practice physical activity. Nevertheless, the recommendations are not widely respected due to the intensity of exercises. Oxygen consumption is a parameter to assess the intensity of physical activity. in this sense, we want to measure the oxygen consumption during various walking tasks compared to healthy controls.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 26, 2023 |
Est. primary completion date | June 26, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Common to both groups: - Age >=18 years - Able to give consent - Not under guardianship or curatorship - Enrolled in the French social security system Specific to the cerebrovascular accident Group: - Stroke confirmed by brain imaging - Able to walk stairs without human assistance (modified Functional Ambulation Classification >= 6) Healthy Group Specific: - Individuals matched to stroke individuals on age sex and BMI. Exclusion Criteria: Cerebrovascular accident group - Severe cognitive impairment (MoCA < 18) Common to both groups: - Presence of contraindication to physical activity: unstable diabetes, unstable hypertension, unstable angina, intra-cardiac thrombus. |
Country | Name | City | State |
---|---|---|---|
France | Limoges university hospital | Limoges |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Limoges |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oxygen consumption measurement | Oxygen consumption by indirect calorimetry (respiratory gas exchange analyzer: Metamax) expressed in mL.min-1.kg-1 | Day 1 | |
Primary | Oxygen consumption measurement | Oxygen consumption by indirect calorimetry (respiratory gas exchange analyzer: Metamax) expressed in mL.min-1.kg-1 | Day 7 | |
Secondary | Walking speed measurement | Average walking speed measured (distance walked/total time) during different travel activities | Day 1 | |
Secondary | Walking speed measurement | Average walking speed measured (distance walked/total time) during different travel activities | Day 7 | |
Secondary | Cardiac frequency measurement | Average heart rate during activity measured by heart rate meter in bpm | Day 1 | |
Secondary | Cardiac frequency measurement | Average heart rate during activity measured by heart rate meter in bpm | Day 7 | |
Secondary | Perception of effort | Perception of effort by the Borg scale during the last minute of the movement activity | Day 1 | |
Secondary | Perception of effort | Perception of effort by the Borg scale during the last minute of the movement activity | Day 7 | |
Secondary | Total energy expenditure | Total energy expenditure during each movement activity estimated by an Actigraph GT3X placed at the healthy ankle | Day 1 | |
Secondary | Total energy expenditure | Total energy expenditure during each movement activity estimated by an Actigraph GT3X placed at the healthy ankle | Day 7 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
Terminated |
NCT00120289 -
Niacin Plus Statin to Prevent Vascular Events
|
Phase 3 | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|